Prostate Cancer (MSK, Science 2022)
Targeted sequencing and whole exome sequencing of 35 prostate cancer tumors, organoids and cell lines via MSK-IMPACT.
Can it answer your research question?
1 of 6 supportedOverall survival
LimitedVital status is informative for 49% of cases, but too few events or no time to event.API
Progression or recurrence
Not measuredThis field was not among those probed for this repository.
Treatment response
Not supportedNo treatment response is recorded in the harmonized records.API
Which drug was given
Not measuredThis field was not among those probed for this repository.
Stage-adjusted modelling
Not measuredThis field was not among those probed for this repository.
Analysis by race or ethnicity
SupportedRACE is informative for 51% of cases.API
At a glance
Every percentage is the repository’s own record of what is filled inSubjectCALC
As filed by the repository
Who is in the cohortAPI
- Sex31 Male · 8 no value recorded
- Race15 WHITE · 2 Caucasian · 1 ASIAN-FAR EAST/INDIAN SUBCONT · 1 UNKNOWN · 20 no value recorded
- Ethnicity13 Non-Spanish; Non-Hispanic · 3 Spanish NOS; Hispanic NOS, Latino NOS · 2 Caucasian · 1 Unknown whether Spanish or not · 20 no value recorded
- Vital status15 DECEASED · 2 LIVING · 22 no value recorded
What was measured, and on how many
- Mutation calls (panel, exome or genome)47 of 47 samples · 100%
- Copy number alterations47 of 47 samples · 100%
- Structural variants / fusions
How complete all 7 clinical fields are - 2 informative for at least 80% of cases
Access
Processed data download from the cBioPortal study page or its public REST API; no account required. Primary raw data remain wherever the original investigators deposited them.
- Open components
- harmonized mutation, copy-number, expression and clinical files
- License
- Per-study terms; cBioPortal asks that the original study be cited
- Citation requirement
- Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.
What it is good for
Written and checked by a reviewer, not generated from metadata.
No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.
What it cannot tell you
Written by a reviewer against the source, not inferred from what is missing.
No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.
Who has used it
Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.
- Not assessed: this dataset has no accession specific enough for citation-based reuse tracing, so a shortfall cannot be measured.
Original publication
Articles that analyzed the data
Not searchable. See the note above.
Community examples
Share your exampleAnalyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.
Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.
Start here
Starter code generated from this record’s own identifiers, then the access steps.
Get the data in code
cBioPortal: clinical data and the full study bundlepython
import requests, pandas as pd
STUDY = "prad_organoids_msk_2022"
base = "https://www.cbioportal.org/api"
clin = requests.get(f"{base}/studies/{STUDY}/clinical-data",
params={"clinicalDataType": "PATIENT", "projection": "SUMMARY"}, timeout=60).json()
patients = pd.DataFrame(clin).pivot_table(index="patientId", columns="clinicalAttributeId",
values="value", aggfunc="first")
print(patients.shape)
profiles = requests.get(f"{base}/studies/{STUDY}/molecular-profiles", timeout=60).json()
print([p["molecularProfileId"] for p in profiles])
# Whole study as flat files: https://cbioportal-datahub.s3.amazonaws.com/prad_organoids_msk_2022.tar.gzThis page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/cbio-prad-organoids-msk-2022.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'Access steps
- Open the study in cBioPortalFor people
Harmonized molecular and clinical files are open. Cite the original publication, and cite cBioPortal if the portal's harmonized files were used.
https://www.cbioportal.org/study/summary?id=prad_organoids_msk_2022 - Download the whole study as a zipFor people
The datasets page carries the staging files used by the portal.
https://www.cbioportal.org/datasets - Or pull the staging files with git-lfsFor people
Study folders are named by study id under public/.
https://github.com/cBioPortal/datahubgit clone https://github.com/cBioPortal/datahub.git && cd datahub git -c lfs.fetchexclude="" lfs pull -I public/prad_organoids_msk_2022 - Read the study straight from the REST APIFor agents
No key is required; pace requests when sweeping many studies.
https://docs.cbioportal.org/web-api-and-clients/curl -s 'https://www.cbioportal.org/api/studies/prad_organoids_msk_2022/clinical-data?clinicalDataType=PATIENT&projection=SUMMARY'
Provenance
All of it, and more, is in this record’s JSON.
Identifiers
- cBioPortal studyprad_organoids_msk_2022API
Versions and verification
- Metadata retrieved
- 18 Sept 2026
- Review status
- Machine-extracted
- Data generation funding
- Funded data generation
Funding
Funded data generation
- U54CA224079Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapyYu Chen, CHARLES L. SAWYERSAPI
- U01CA252048Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)Ping ChiAPI
- U01CA224044Patient-Derived Models of Prostate Cancer for Personalized MedicineYu Chen, PHILLIP ANDREW FUTREALAPI
- R37CA241486Molecular mechanisms underlying lineage plasticity in prostate cancerHimisha BeltranAPI
- R01CA228216Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancerPing ChiAPI
- R01CA218668Computational and experimental methods for scalable identification of oncogenic non-coding regionsEKTA KHURANA, Neville SanjanaAPI
- R01CA208100Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistanceYu ChenAPI
- R01CA193837Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependenceCHARLES L. SAWYERSAPI
- P50CA221745Biospecimen Repository CoreHikmat Al-Ahmadie, David B. SolitAPI
- P50CA211024Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate CancerHimisha Beltran, David S. RickmanAPI